Regentis Biomaterials Ltd.
RGNT
New York Stock Exchange Arca1.97
USD
-0.05
- -
Total Valuation
Regentis Biomaterials Ltd. carries a market capitalization of 13.84M, placing it among publicly traded companies globally.
| Market Cap | 13.84M |
| Enterprise Value | N/A |
Stock Price Statistics
Regentis Biomaterials Ltd.'s stock has declined approximately -73.73333% over the past 52 weeks. The 50-day moving average sits at 2.50, while the 200-day moving average is 3.76.
| Beta (5Y) | N/A |
| 52-Week Price Change | -73.73333% |
| 50-Day Moving Average | 2.50 |
| 200-Day Moving Average | 3.76 |
| Average Volume (20 Days) | N/A |